- Home
- MSN vs BOLT Comparison
MSN vs BOLT Comparison
Compare MSN & BOLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MSN | BOLT |
|---|---|---|
| Founded | 1948 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Consumer Electronics/Appliances | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.9M | 10.5M |
| IPO Year | 1994 | 2021 |
Fundamental Metrics
Financial Performance| Metric | MSN | BOLT |
|---|---|---|
| Price | $0.39 | $5.30 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $34.00 |
| AVG Volume (30 Days) | ★ 40.3K | 31.5K |
| Earning Date | 02-13-2026 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $8,739,000.00 | $5,195,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.28 | $4.41 |
| 52 Week High | $0.85 | $12.60 |
Technical Indicators
Market Signals| Indicator | MSN | BOLT |
|---|---|---|
| Relative Strength Index (RSI) | 40.53 | 49.12 |
| Support Level | $0.38 | $5.09 |
| Resistance Level | $0.42 | $5.71 |
| Average True Range (ATR) | 0.02 | 0.39 |
| MACD | 0.00 | -0.02 |
| Stochastic Oscillator | 10.68 | 23.48 |
Price Performance
Historical ComparisonAbout MSN Emerson Radio Corporation
Emerson Radio Corp operates in the consumer electronics industry. The company designs, sources, imports, and markets a variety of houseware and consumer electronic products, and licenses the Emerson trademark domestically and internationally. The products offered by the company are televisions, digital versatile disc players and video cassette recorders, audio accessories, microwave ovens, home theatres, high-end audio products, office products, mobile stereo, and wireless products.
About BOLT Bolt Biotherapeutics Inc.
Bolt Biotherapeutics Inc is a clinical-stage immuno-oncology company. It is developing tumor-targeted therapies that leverage the power of the innate and adaptive immune systems. The company's pipeline candidates are built on deep expertise in myeloid biology and cancer drug development. The company's proprietary Boltbody ISAC platform technology combines tumor-targeting antibodies with immune-stimulating linker-payloads. The company's pipeline consists of BDC-1001, BDC-3042, and Next-Gen ISAC.